Mycoplasma pneumoniae community-acquired pneumonia at three hospitals in Bangkok

Chutima Chaoprasong1, Nonglak Chanthadisai, Unchala Buasap

  • 1Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

Abstract

Insights

Mycoplasma pneumoniae is a frequent cause of community-acquired pneumonia (CAP) in young adults in Bangkok. This study found it in 21.3% of adult CAP cases, with typical symptoms like cough and fever.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in children and young adults.
  • No prior prospective studies in Thailand evaluated M. pneumoniae in adult CAP patients.

Purpose of the Study:

  • To determine the prevalence of M. pneumoniae in adult CAP patients in Thailand.
  • To describe the clinical and laboratory features of M. pneumoniae CAP in adults.

Main Methods:

  • Prospective study of adult CAP patients at three general hospitals (September 1998 - August 1999).
  • Paired sera tested for M. pneumoniae using particle agglutination.
  • Definite diagnosis based on a fourfold increase in antibody titer.

Main Results:

  • Seventeen (21.3%) of 80 CAP patients had M. pneumoniae pneumonia.
  • Mean age was 28.3 years; common symptoms included cough (100%), fever (82.4%), and headache (47%).
  • Radiographic findings included alveolar shadowing (53%) and mixed alveolar/interstitial shadowing (29.4%); all patients survived.

Conclusions:

  • M. pneumoniae is a significant cause of CAP in Bangkok, Thailand.
  • This pneumonia commonly affects young adults and is often treatable as an outpatient condition.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: